| The decision could dramatically broaden the availability of the nasal spray version of naloxone, which requires no special training to administer and has been credited with saving thousands of lives. The over-the-counter version is expected to be made available sometime this summer, but the long-term impact remains unclear – it will depend on the price set for the spray by its manufacturer, Emergent BioSolutions, as well as retailers' willingness to stock it on store shelves in easy view of consumers. | 
No comments:
Post a Comment